Monoclonal antibody inhibition of PAR2 reduces phenotype severity and pain in murine inflammatory bowel disease. - Ritoux A; Grundy LJ; Manjappa P; Paine LW; Neisen J; Linley JE; Smith ESJ (Pain reports, 2026)